RGD-FasL Induces Apoptosis in Hepatocellular Carcinoma

Despite impressive results obtained in animal models, the clinical use of Fas ligand (FasL) as an anticancer drug is limited by severe toxicity. Systemic toxicity of death ligands may be prevented by using genes encoding membrane-bound death ligands and by targeted transgene expression through eithe...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Liu, Zhongchen, Wang, Juan, Yin, Ping, Qiu, Jinhua, Liu, Ruizhen, Li, Wenzhu, Fan, Xin, Cheng, Xiaofeng, Chen, Caixia, Zhang, Jiakai, Zhuang, Guohong
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2009
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4002720/
https://ncbi.nlm.nih.gov/pubmed/19728930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cmi.2009.38
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares